Abstract
Purpose
To present the long-term results of ab externo trabeculotomy in the management of glaucoma secondary to chronic uveitis.
Methods
In this retrospective single-centre case series, medical records of patients with glaucoma secondary to chronic uveitis, who underwent ab externo trabeculotomy, were evaluated. Two definitions of success were used: intraocular pressure (IOP) 6 ≤ IOP ≤ 21 mmHg (success 1) or 6 ≤ IOP ≤ 21 mmHg and at least 25 % reduction from baseline (success 2). Success was complete when no additional medication was required or qualified when additional medication or cycloablative procedures were required to achieve the specific IOP definition.
Results
Twenty-two eyes of 18 patients were included. After 3 years, median IOP decreased from 27 mmHg [range 17–43 mmHg, mean 27.5 mmHg, 95 % confidence interval of the mean (CI) 24.5–30.5 mmHg] to 15 mmHg (range 9–19 mmHg, mean 14.5 mmHg, CI 13–16.1 mmHg). Complete and qualified success 1 was 23 and 45 % after 3 years, respectively. For success 2, the rates were 23 and 32 %, respectively. Hyphema was the most common complication, which resolved completely within 1 month after surgery without further intervention.
Conclusion
Trabeculotomy ab externo was moderately successful in glaucoma secondary to chronic uveitis after 3 years. No sight-threatening complications were observed during the follow-up period.
Similar content being viewed by others
References
Merayo-Lloves J, Power WJ, Rodriguez A, Pedroza-Seres M, Foster CS (1999) Secondary glaucoma in patients with uveitis. Ophthalmologica 213:300–304
Panek WC, Holland GN, Lee DA, Christensen RE (1990) Glaucoma in patients with uveitis. Br J Ophthalmol 74:223–227
Takahashi T, Ohtani S, Miyata K, Miyata N, Shirato S, Mochizuki M (2002) A clinical evaluation of uveitis-associated secondary glaucoma. Jpn J Ophthalmol 46:556–562
Deuter CM, Klinik T, Muller M, Geerling G, Zierhut M (2010) Secondary glaucoma in uveitis. Ophthalmologe 107:427–434
Heinz C, Pleyer U, Ruokonnen P, Heiligenhaus A (2008) Secondary glaucoma in childhood uveitis. Ophthalmologe 105:438–444
Moorthy RS, Mermoud A, Baerveldt G, Minckler DS, Lee PP, Rao NA (1997) Glaucoma associated with uveitis. Surv Ophthalmol 41:361–394
Sung VC, Barton K (2004) Management of inflammatory glaucomas. Curr Opin Ophthalmol 15:136–140
Auer C, Mermoud A, Herbort CP (2004) Deep sclerectomy for the management of uncontrolled uveitic glaucoma: preliminary data. Klin Monatsbl Augenheilkd 221:339–342
Ceballos EM, Beck AD, Lynn MJ (2002) Trabeculectomy with antiproliferative agents in uveitic glaucoma. J Glaucoma 11:189–196
Ceballos EM, Parrish RK 2nd, Schiffman JC (2002) Outcome of Baerveldt glaucoma drainage implants for the treatment of uveitic glaucoma. Ophthalmology 109:2256–2260
Chawla A, Mercieca K, Fenerty C, Jones NP (2013) Outcomes and complications of trabeculectomy enhanced with 5-fluorouracil in adults with glaucoma secondary to uveitis. J Glaucoma 22:663–666
Dupas B, Fardeau C, Cassoux N, Bodaghi B, LeHoang P (2010) Deep sclerectomy and trabeculectomy in uveitic glaucoma. Eye (Lond) 24:310–314
Heinz C, Koch JM, Heiligenhaus A (2006) Transscleral diode laser cyclophotocoagulation as primary surgical treatment for secondary glaucoma in juvenile idiopathic arthritis: high failure rate after short term follow up. Br J Ophthalmol 90:737–740
Hill RA, Nguyen QH, Baerveldt G, Forster DJ, Minckler DS, Rao N, Lee M, Heuer DK (1993) Trabeculectomy and molteno implantation for glaucomas associated with uveitis. Ophthalmology 100:903–908
Iwao K, Inatani M, Seto T, Takihara Y, Ogata-Iwao M, Okinami S, Tanihara H (2014) Long-term outcomes and prognostic factors for trabeculectomy with mitomycin C in eyes with uveitic glaucoma: a retrospective cohort study. J Glaucoma 23:88–94
Kaburaki T, Koshino T, Kawashima H, Numaga J, Tomidokoro A, Shirato S, Araie M (2009) Initial trabeculectomy with mitomycin C in eyes with uveitic glaucoma with inactive uveitis. Eye (Lond) 23:1509–1517
Molteno AC, Sayawat N, Herbison P (2001) Otago glaucoma surgery outcome study: long-term results of uveitis with secondary glaucoma drained by molteno implants. Ophthalmology 108:605–613
Noble J, Derzko-Dzulynsky L, Rabinovitch T, Birt C (2007) Outcome of trabeculectomy with intraoperative mitomycin C for uveitic glaucoma. Can J Ophthalmol 42:89–94
Papadaki TG, Zacharopoulos IP, Pasquale LR, Christen WB, Netland PA, Foster CS (2007) Long-term results of Ahmed glaucoma valve implantation for uveitic glaucoma. Am J Ophthalmol 144:62–69
Schlote T, Derse M, Zierhut M (2000) Transscleral diode laser cyclophotocoagulation for the treatment of refractory glaucoma secondary to inflammatory eye diseases. Br J Ophthalmol 84:999–1003
Stavrou P, Murray PI (1999) Long-term follow-up of trabeculectomy without antimetabolites in patients with uveitis. Am J Ophthalmol 128:434–439
Voykov B, Deuter C, Zierhut M, Leitritz MA, Guenova E, Doycheva D (2014) Is cyclophotocoagulation an option in the management of glaucoma secondary to Fuchs’ uveitis syndrome? Graefes Arch Clin Exp Ophthalmol 252:485–489
Tanihara H, Negi A, Akimoto M, Terauchi H, Okudaira A, Kozaki J, Takeuchi A, Nagata M (1993) Surgical effects of trabeculotomy ab externo on adult eyes with primary open angle glaucoma and pseudoexfoliation syndrome. Arch Ophthalmol 111:1653–1661
Heinz C, Koch JM, Zurek-Imhoff B, Heiligenhaus A (2009) Prevalence of uveitic secondary glaucoma and success of nonsurgical treatment in adults and children in a tertiary referral center. Ocul Immunol Inflamm 17:243–248
Neri P, Azuara-Blanco A, Forrester JV (2004) Incidence of glaucoma in patients with uveitis. J Glaucoma 13:461–465
Souissi K, El Afrit MA, Trojet S, Kraiem A (2006) Deep sclerectomy for the management of Uveitic glaucoma. J Fr Ophtalmol 29:265–268
Khairy HA, Green FD, Nassar MK, Azuara-Blanco A (2006) Control of intraocular pressure after deep sclerectomy. Eye (Lond) 20:336–340
Gedde SJ, Singh K, Schiffman JC, Feuer WJ, Tube Versus Trabeculectomy Study G (2012) The tube versus trabeculectomy study: interpretation of results and application to clinical practice. Curr Opin Ophthalmol 23:118–126
Eibschitz-Tsimhoni M, Schertzer RM, Musch DC, Moroi SE (2005) Incidence and management of encapsulated cysts following Ahmed glaucoma valve insertion. J Glaucoma 14:276–279
Gil-Carrasco F, Salinas-VanOrman E, Recillas-Gispert C, Paczka JA, Gilbert ME, Arellanes-Garcia L (1998) Ahmed valve implant for uncontrolled uveitic glaucoma. Ocul Immunol Inflamm 6:27–37
Lai JS, Poon AS, Chua JK, Tham CC, Leung AT, Lam DS (2000) Efficacy and safety of the Ahmed glaucoma valve implant in Chinese eyes with complicated glaucoma. Br J Ophthalmol 84:718–721
Ozdal PC, Vianna RN, Deschenes J (2006) Ahmed valve implantation in glaucoma secondary to chronic uveitis. Eye (Lond) 20:178–183
Anton A, Heinzelmann S, Ness T, Lubke J, Neuburger M, Jordan JF, Wecker T (2015) Trabeculectomy ab interno with the trabectome(R) as a therapeutic option for uveitic secondary glaucoma. Graefes Arch Clin Exp Ophthalmol 251:2753–2760
Costa VP, Katz LJ, Spaeth GL, Smith M, Gandham S (1993) Primary trabeculectomy in young adults. Ophthalmology 100:1071–1076
Investigators A (2002) The advanced glaucoma intervention study (AGIS): 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty. Am J Ophthalmol 134:481–498
Bonfioli AA, Curi AL, Orefice F (2005) Fuchs’ heterochromic cyclitis. Semin Ophthalmol 20:143–146
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
No funding was received for this research.
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Voykov, B., Dimopoulos, S., Leitritz, M.A. et al. Long-term results of ab externo trabeculotomy for glaucoma secondary to chronic uveitis. Graefes Arch Clin Exp Ophthalmol 254, 355–360 (2016). https://doi.org/10.1007/s00417-015-3204-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-015-3204-y